Fingerprint
Dive into the research topics of 'Identification of risk factors for toxicity in patients with hormone receptor-positive advanced breast cancer treated with bevacizumab plus letrozole: a CALGB 40503 (alliance) correlative study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically